Equillium, Inc. Common Stock

EQNASDAQ • USD
1.15 USD
↘ 0.14 (10.90%)AT CLOSE (03:59 PM EST)
1.16
↗ 0.01 (1.04%)
POST MARKET (AS OF 04:23 PM EST)
Post Market
AS OF 04:23 PM EST
1.16
↗ 0.01 (1.04%)
🔴Market: CLOSED

Equillium, Inc. Common Stock (EQ) is currently trading at $1.15. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.23
High?$1.29
Low?$1.13
Prev. Close?$1.29
Volume?570.7K
Avg. Volume?446.0K
VWAP?$1.20
Rel. Volume?1.28x
Bid / Ask
Bid?$1.12 × 200
Ask?$1.20 × 400
Spread?$0.08
Midpoint?$1.16
Valuation & Ratios
Market Cap?94.7M
Shares Out?78.4M
Float?44.8M
Float %?70.8%
P/E Ratio?N/A
P/B Ratio?1.80
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Employees
14
Market Cap
106.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-10-12
Address
2223 AVENIDA DE LA PLAYA
LA JOLLA, CA 92037
Phone: (858) 412-5302
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?12.30Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.23%High
Short Interest?5.9M
Days to Cover?9.5
Free Float44.8M
Avg Daily Volume622.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?19.49Strong
Quick Ratio?19.49Strong
Cash Ratio?18.92Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
80
1.80CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
5
-34.8%WEAK▾
ROA?
S&P
3
-32.9%WEAK▾
Cash Flow & Enterprise
FCF?$-15484000
Enterprise Value?$41.4M
Fundamentals ratios updated end of day